Trends & Challenges in Peptide, Oligonucleotide and Small Molecule Drug Discovery & Development
AGENDA
11:00 – 11:05 | Introduction
11:05 – 11:15 | Alex Satz, WuXi Biology “DNA-Encoded Libraries and mRNA Display Empower Early Discovery of Peptides with Therapeutic Potential”
11:15 – 11:25 | Michael Drosch, WuXi TIDES “Integrated Platform for Peptide Synthesis & Manufacturing”
11:25 – 11:40 | Special Guest: Christian Heinis Lab, EPFL “Developing Membrane-Permeable Cyclic Peptides”
11:40 – 11:50 | Robert Judkins, WuXi Project Management “Expanding Therapeutics with New Modalities”
11:50 – 12:05 | Special Guest: Luc Otten, theraPPi “Beyond Daraxonrasib, the Wonder Drug Approved in 2026 in Pancreas Cancer”
12:05 – 12:15 | Yun Yang, WuXi Oligonucleotides Discovery Chemistry “Integrated Platform to Accelerate Drug Discovery on Oligonucleotide Conjugates”
12:15 – 12:25 | Lijuan Pang, WuXi Biology “From Oligo Design to Delivery: An Integrated Approach”
12:25 – 12:40 | Special Guest: Sonja Merkas, Livinovea “Navigating Regulatory Requirements in Oligonucleotide Development”
12:40 – 14:30 | Lunch & Networking